drugset / Trial / NCT04410874
Imvamune Vaccine for the Treatment of Non-melanoma Skin Cancer
NaSequentialOpen-labelTreatment
Summary
This study examines the safety and efficacy of using the Imvamune smallpox vaccine in the treatment of non-melanoma skin cancers (basal cell carcinoma and squamous cell carcinoma).
Timeline
- Start
- 2020-11-16
- Primary completion
- 2023-05-23
- Completion
- 2023-05-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IMVAMUNE | Vaccine | 1e+07 unknown | Other |
| Subject | IMVAMUNE | Vaccine | 1e+08 unknown | Other |
| Subject | IMVAMUNE | Vaccine | 4e+08 unknown | Other |